Silgan (SLGN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 results were at the high end of guidance, with net sales reaching $1.6 billion, up 6% year-over-year, reflecting strong execution and resilience amid dynamic market and operating conditions.
The business benefited from a diverse portfolio, long-term customer partnerships, and a low-cost global manufacturing footprint.
Double-digit organic volume growth was achieved in fragrance and beauty dispensing products and metal containers for pet food, with the Weener integration driving innovation.
Metal Containers saw 2% volume growth year-over-year, led by 11% growth in pet food, offset by lower fruit and vegetable volumes due to pre-buying.
Custom Containers volumes were below prior year due to destocking and cost reduction activities, but are expected to recover in the second half.
Financial highlights
Net sales reached $1.6 billion, up 6% year-over-year, driven by higher raw material costs pass-through and favorable FX.
Adjusted EBIT was $152 million, down 4% from the prior year, with segment performance mixed and higher corporate expense.
Adjusted EPS was $0.78, down $0.04 year-over-year, impacted by lower EBIT and higher tax rate, partially offset by lower interest expense.
Dispensing and Specialty Closures sales rose 2%, but Adjusted EBIT declined due to adverse volume/mix and higher inventory costs.
Metal Containers sales increased 15% year-over-year, with Adjusted EBIT flat as pet food gains offset fruit/vegetable declines.
Custom Containers sales fell 10% due to business exits and destocking; Adjusted EBIT was lower on reduced volumes.
Outlook and guidance
2026 Adjusted EPS guidance raised by $0.03 to $3.73–$3.93, exceeding prior record levels at the low end.
Q2 2026 Adjusted EPS expected at $0.92–$1.02 vs. $1.01 prior year; Q2 interest expense guided at $50 million, tax rate 25–26%.
Dispensing and Specialty Closures volumes expected to grow low to mid-single digits in 2026, led by dispensing products.
Metal Containers volumes to grow low single digits, driven by pet food; Custom Containers volumes to recover in H2.
Free cash flow for 2026 estimated at $450 million, with CapEx of $310 million.
Latest events from Silgan
- Proxy covers director elections, incentive plan amendment, auditor ratification, and say-on-pay.SLGN
Proxy filing16 Apr 2026 - Record 2025 growth in key segments, with further earnings and cash flow gains expected in 2026.SLGN
Q4 20254 Feb 2026 - €838M acquisition expands dispensing leadership, targets €20M synergies and 10% EPS accretion.SLGN
M&A Announcement3 Feb 2026 - Q2 net sales fell 3.2% to $1.38B, but gross margin and adjusted EPS both increased.SLGN
Q2 20242 Feb 2026 - Q3 2024 saw record dispensing growth and Weener acquisition, setting up strong 2025 prospects.SLGN
Q3 202417 Jan 2026 - Record Q4 results and 2025 double-digit growth outlook driven by acquisitions and dispensing demand.SLGN
Q4 20249 Jan 2026 - Record Q1 2025 sales and earnings growth driven by Weener acquisition and volume gains.SLGN
Q1 202524 Dec 2025 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance.SLGN
Proxy Filing1 Dec 2025 - Record Q2 sales, 15% EPS growth, and strong outlook despite $20M EBIT headwinds.SLGN
Q2 202516 Nov 2025